Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 17 Gynecologic 6 CNS 5 Sarcoma 3 Thoracic 2 Head & Neck 2 Genitourinary 2 Gastrointestinal 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 141 Lenalidomide 60 Bortezomib 56 Calcium Dobesilate 47 Melphalan 44 carfilzomib 40 pomalidomide 39 Cyclophosphamide 38 daratumumab 27 belantamab mafodotin 22 ixazomib 19 Peripheral Blood Stem Cell Transplantation 18 fludarabine phosphate 16 fludarabine 16 dexamethasone acetate 14 Bendamustine Hydrochloride 14 Whole-Body Irradiation 13 Filgrastim 13 dexamethasone 21-phosphate 12 Tacrolimus 12 venetoclax 11 auricularum 11 Prednisone 11 selinexor 10 liposomal doxorubicin 10 iberdomide 10 Mycophenolic Acid 10 Cyclosporine 9 pembrolizumab 8 isatuximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × abemaciclib × Plasma cell × Clear all

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡